Search results
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
The Joplin Globe· 6 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Moderna wins second product approval with RSV vaccine
Market Watch· 6 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 6 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Arizona Daily Sun· 3 days agoModerna and partner Merck & Co said on Monday their cancer vaccine in combination with blockbuster...
FDA Green-Lights Moderna Vaccine for Older Adults | Newswise
Newswise· 19 hours agoThe US Food and Drug Administration has approved Moderna’s mRNA vaccine for older adults to protect against respiratory syncytial virus (RSV). According to a company press ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 3 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 3 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 6 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 6 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 4 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.